The Gersbach and Asokan Labs receive a Duke-UNC Clinical and Translational Science Award (CTSA) Consortium Collaborative Translational Research Grant to collaborate on developing in vivo genome editing technologies.

December 12, 2014

The Gersbach and Asokan Labs receive a Duke-UNC Clinical and Translational Science Award (CTSA) Consortium Collaborative Translational Research Grant to collaborate on developing in vivo genome editing technologies.